BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kohsaka S, Katada J, Saito K, Jenkins A, Li B, Mardekian J, Terayama Y. Safety and effectiveness of non-vitamin K oral anticoagulants versus warfarin in real-world patients with non-valvular atrial fibrillation: a retrospective analysis of contemporary Japanese administrative claims data. Open Heart 2020;7:e001232. [PMID: 32341789 DOI: 10.1136/openhrt-2019-001232] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Lip GYH, Keshishian A, Kang A, Luo X, Atreja N, Zhang Y, Schuler P, Jiang J, Yuce H, Deitelzweig S. Effectiveness and safety of oral anticoagulants in non-valvular atrial fibrillation patients with prior bleeding events: a retrospective analysis of administrative claims databases. J Thromb Thrombolysis 2022. [PMID: 35579733 DOI: 10.1007/s11239-022-02660-2] [Reference Citation Analysis]
2 Kim SM, Jeon ET, Jung JM, Lee JS. Real-world oral anticoagulants for Asian patients with non-valvular atrial fibrillation: A PRISMA-compliant article. Medicine (Baltimore) 2021;100:e26883. [PMID: 34397907 DOI: 10.1097/MD.0000000000026883] [Reference Citation Analysis]
3 Qian J, Yan YD, Yang SY, Zhang C, Li WY, Gu ZC. Benefits and Harms of Low-Dose Rivaroxaban in Asian Patients With Atrial Fibrillation: A Systematic Review and Meta-analysis of Real-World Studies. Front Pharmacol 2021;12:642907. [PMID: 34211392 DOI: 10.3389/fphar.2021.642907] [Reference Citation Analysis]
4 Han S, Han S, Suh HS, Bang OY, On YK, Lee MY, Jang SW, Won MM, Park YJ, Lee JM, Kang S, Kim YH. Effectiveness and safety of non-vitamin K antagonist oral anticoagulants in patients with non-valvular atrial fibrillation: A nationwide, population-based study in Korea. J Arrhythm 2021;37:1240-9. [PMID: 34621422 DOI: 10.1002/joa3.12607] [Reference Citation Analysis]
5 Li Z, Wang X, Li D, Wen A, Della Rocca D. Real-World Comparisons of Low-Dose NOACs versus Standard-Dose NOACs or Warfarin on Efficacy and Safety in Patients with AF: A Meta-Analysis. Cardiology Research and Practice 2022;2022:1-10. [DOI: 10.1155/2022/4713826] [Reference Citation Analysis]
6 Crocetti E, Cattaneo S, Bergamaschi W, De Servi S, Russo AG. Effectiveness and Safety of Non-Vitamin K Oral Anticoagulants in Non-Valvular Atrial Fibrillation Patients: Results of A Real-World Study in a Metropolitan Area of Northern Italy. J Clin Med 2021;10:4536. [PMID: 34640554 DOI: 10.3390/jcm10194536] [Reference Citation Analysis]
7 Waranugraha Y, Rizal A, Syaban MFR, Faratisha IFD, Erwan NE, Yunita KC. Direct comparison of non-vitamin K antagonist oral anticoagulant versus warfarin for stroke prevention in non-valvular atrial fibrillation: a systematic review and meta-analysis of real-world evidences. Egypt Heart J 2021;73:70. [PMID: 34379219 DOI: 10.1186/s43044-021-00194-1] [Reference Citation Analysis]
8 Chong DT, Andreotti F, Verhamme P, Dalal J, Uaprasert N, Wang CC, On YK, Li YH, Jiang J, Hasegawa K, Almuti K, Bai R, Lo ST, Krittayaphong R, Lee LH, Quek DK, Johar S, Seow SC, Hammett CJ, Tan JW. Direct Oral Anticoagulants in Asian Patients with Atrial Fibrillation: Consensus Recommendations by the Asian Pacific Society of Cardiology on Strategies for Thrombotic and Bleeding Risk Management. Eur Cardiol 2021;16:e23. [PMID: 34135993 DOI: 10.15420/ecr.2020.43] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Laurent T, Simeone J, Kuwatsuru R, Hirano T, Graham S, Wakabayashi R, Phillips R, Isomura T. Context and Considerations for Use of Two Japanese Real-World Databases in Japan: Medical Data Vision and Japanese Medical Data Center. Drugs Real World Outcomes 2022. [PMID: 35304702 DOI: 10.1007/s40801-022-00296-5] [Reference Citation Analysis]
10 Liu F, Yang Y, Cheng W, Ma J, Zhu W. Reappraisal of Non-vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients: A Systematic Review and Meta-Analysis. Front Cardiovasc Med 2021;8:757188. [PMID: 34722686 DOI: 10.3389/fcvm.2021.757188] [Reference Citation Analysis]
11 Zhu L, Zhang X, Yang J. Analysis of Influencing Factors of Compliance with Non-Vitamin K Antagonist Oral Anticoagulant in Patients with Nonvalvular Atrial Fibrillation and Correlation with the Severity of Ischemic Stroke. Evid Based Complement Alternat Med 2021;2021:1021127. [PMID: 34712338 DOI: 10.1155/2021/1021127] [Reference Citation Analysis]